Capricor Therapeutics (CAPR) Total Liabilities (2016 - 2025)
Historic Total Liabilities for Capricor Therapeutics (CAPR) over the last 17 years, with Q3 2025 value amounting to $42.6 million.
- Capricor Therapeutics' Total Liabilities rose 7244.52% to $42.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.6 million, marking a year-over-year increase of 7244.52%. This contributed to the annual value of $25.0 million for FY2024, which is 3075.9% down from last year.
- Per Capricor Therapeutics' latest filing, its Total Liabilities stood at $42.6 million for Q3 2025, which was up 7244.52% from $28.6 million recorded in Q2 2025.
- Capricor Therapeutics' Total Liabilities' 5-year high stood at $47.7 million during Q1 2023, with a 5-year trough of $6.4 million in Q3 2021.
- Over the past 5 years, Capricor Therapeutics' median Total Liabilities value was $31.0 million (recorded in 2024), while the average stood at $29.3 million.
- In the last 5 years, Capricor Therapeutics' Total Liabilities soared by 50493.84% in 2022 and then crashed by 3813.51% in 2024.
- Over the past 5 years, Capricor Therapeutics' Total Liabilities (Quarter) stood at $10.0 million in 2021, then surged by 284.54% to $38.3 million in 2022, then decreased by 5.68% to $36.1 million in 2023, then crashed by 30.76% to $25.0 million in 2024, then soared by 70.16% to $42.6 million in 2025.
- Its Total Liabilities was $42.6 million in Q3 2025, compared to $28.6 million in Q2 2025 and $26.1 million in Q1 2025.